KAINOS Laboratories (TSE:4556) OCF Margin %: 17.50% (As of Mar. 2026) — 65% Above Median


TSE:4556 KAINOS Laboratories Inc TSE:4556
39 GF Score
Price 円2,268.00
GF Value 円1,281.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is KAINOS Laboratories OCF Margin %?

KAINOS Laboratories TSE:4556 39 OCF Margin % is 17.50% as of Mar. 2026, which is 65% above its 10-year median of 10.59. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, KAINOS Laboratories ranks better than 58.21% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. KAINOS Laboratories's Cash Flow from Operations for the six months ended in Mar. 2026 was 円474 Mil. KAINOS Laboratories's Revenue for the six months ended in Mar. 2026 was 円2,712 Mil. Therefore, KAINOS Laboratories's OCF Margin % for the quarter that ended in Mar. 2026 was 17.50%.

As of today, KAINOS Laboratories's current OCF Yield % is 5.55%.

The historical rank and industry rank for KAINOS Laboratories's OCF Margin % or its related term are showing as below:

TSE:4556' s OCF Margin % Range Over the Past 10 Years
Min: 7.7   Med: 10.59   Max: 14.71
Current: 10.11


During the past 13 years, the highest OCF Margin % of KAINOS Laboratories was 14.71%. The lowest was 7.70%. And the median was 10.59%.

TSE:4556's OCF Margin % is ranked better than
58.21% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 5.84 vs TSE:4556: 10.11


KAINOS Laboratories OCF Margin % Related Terms


KAINOS Laboratories OCF Margin % Historical Data

* Premium members only.

The historical data trend for KAINOS Laboratories's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KAINOS Laboratories OCF Margin % Chart

KAINOS Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.10 11.06 8.52 13.28 10.11

KAINOS Laboratories Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.12 12.95 13.62 2.87 17.50

TSE:4556 vs ISRG, BDX, MDLN: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KAINOS Laboratories OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's OCF Margin % distribution charts can be found below:

* The bar in red indicates where KAINOS Laboratories's OCF Margin % falls into.


TSE:4556
39GF Score
KAINOS Laboratories Inc TSE:4556
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KAINOS Laboratories OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

KAINOS Laboratories's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=553.735/5479.789
=10.11 %

KAINOS Laboratories's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=474.426/2711.715
=17.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 17.50% mean?
KAINOS Laboratories (TSE:4556) has a OCF Margin % of 17.50% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on KAINOS Laboratories and its competitors. This is 65% above median its historical median of 10.59. Over the past decade, KAINOS Laboratories' OCF Margin % has ranged from 7.70 to 14.71. According to the industry distribution chart, KAINOS Laboratories ranks #341 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 41.8%.
Is KAINOS Laboratories' OCF Margin % too high?
KAINOS Laboratories' current OCF Margin % of 17.50% is 65% above median its 10-year median of 10.59. Over the past 10 years, this metric has ranged from a low of 7.70 to a high of 14.71. The Medical Devices & Instruments industry median OCF Margin % is 5.84. KAINOS Laboratories' value of 17.50% is 199.7% above this industry median. Based on the distribution chart, KAINOS Laboratories ranks #341 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KAINOS Laboratories ranks #341 out of 816 companies for OCF Margin %. This puts KAINOS Laboratories in the upper half of its industry. The industry median OCF Margin % is 5.84. KAINOS Laboratories' value of 17.50% is 199.7% above this benchmark. Historically, KAINOS Laboratories' own OCF Margin % has ranged from 7.70 to 14.71 over the past decade. While the company's 10-year median is 10.59 vs. the industry median of 5.84, KAINOS Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KAINOS Laboratories's current OCF Margin % of 17.50% is 199.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on KAINOS Laboratories and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KAINOS Laboratories's current OCF Margin % is 17.50%, which is 65% above median its own 10-year median of 10.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current OCF Margin % is 17.50%, which is 65% above median its 10-year median of 10.59 and 199.7% above the Medical Devices & Instruments industry median of 5.84. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current OCF Margin % is 17.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?

Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued. The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99. GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.

Key valuation signals for TSE:4556:

  • OCF Margin %: 17.50% (65% above median its 10-year median of 10.59)
  • GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
  • GF Score™: 39/100 with 6 warning signs
  • Industry Position: 199.7% above the Medical Devices & Instruments median (#341 of 816)

No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KAINOS Laboratories Business Description

Address 38-18, Hongo 2-chome, Bunkyo-ku, Tokyo, JPN
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score

Get the complete analysis for TSE:4556

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,268.00
Price
円1,281.99
GF Value